LLY

723.42

-0.41%↓

JNJ

178.06

-0.06%↓

ABBV

209.53

-1.3%↓

UNH

316.45

+0.44%↑

NVO

54.39

-1.32%↓

LLY

723.42

-0.41%↓

JNJ

178.06

-0.06%↓

ABBV

209.53

-1.3%↓

UNH

316.45

+0.44%↑

NVO

54.39

-1.32%↓

LLY

723.42

-0.41%↓

JNJ

178.06

-0.06%↓

ABBV

209.53

-1.3%↓

UNH

316.45

+0.44%↑

NVO

54.39

-1.32%↓

LLY

723.42

-0.41%↓

JNJ

178.06

-0.06%↓

ABBV

209.53

-1.3%↓

UNH

316.45

+0.44%↑

NVO

54.39

-1.32%↓

LLY

723.42

-0.41%↓

JNJ

178.06

-0.06%↓

ABBV

209.53

-1.3%↓

UNH

316.45

+0.44%↑

NVO

54.39

-1.32%↓

Search

DaVita Inc

Abierto

SectorSalud

136.33 -0.94

Resumen

Variación precio

24h

Actual

Mínimo

134.12

Máximo

137.75

Métricas clave

By Trading Economics

Ingresos

43M

275M

Ventas

156M

3.4B

P/B

Media del Sector

13.572

35.733

BPA

2.95

Margen de beneficio

8.144

Empleados

76,000

EBITDA

92M

690M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+8.07% upside

Dividendos

By Dow Jones

Próximas Ganancias

28 oct 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-695M

9.8B

Apertura anterior

137.27

Cierre anterior

136.33

Noticias sobre sentimiento de mercado

By Acuity

12%

88%

9 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

DaVita Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

14 feb 2025, 19:50 UTC

Principales Movimientos del Mercado

DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

21 mar 2025, 08:19 UTC

Charlas de Mercado

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

Comparación entre iguales

Cambio de precio

DaVita Inc Esperado

Precio Objetivo

By TipRanks

8.07% repunte

Estimación a 12 meses

Media 149 USD  8.07%

Máximo 160 USD

Mínimo 137 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para DaVita Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

6 ratings

0

Comprar

5

Mantener

1

Vender

Puntuación técnica

By Trading Central

142.36 / 144.275Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

9 / 371 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
help-icon Live chat